Get startedLog in
    Picture of Aptose Biosciences logo

    APTOF — Aptose Biosciences News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapMomentum Trap
    All News

    Aptose Biosciences Q3 net loss narrows

    Picture of Aptose Biosciences logoAptose Biosciences
    13/11/2025 22:12
    Overview

Aptose reports Q3 net loss of $5.1 mln, down from $7.0 mln last year

Research and development expenses decreased due to reduced clinical and manufacturing activity

Outlook

Company did not provide specific financial guidance

Result Drivers

R&D: Research and development expenses decreased by $2.5 million to $2.2 million for the quarter ended September 30

Key Details


    MetricBeat/MissActualConsensus Estimate
    Q3 Net Income-$5.12 mln
    

Press Release: ID:nGNX3Tlhr0

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

    Recent news on Aptose Biosciences

    See all news